3/2/2009

Cephalon said it plans to offer $318 million to acquire Arana Therapeutics, an Australian company that has "an established protein-engineering technology platform" for turning proteins into potent treatments. Cephalon said Arana's independent directors support the takeover offer and will recommend it to stockholders.

Related Summaries